$Allarity Therapeutics (ALLR.US)$Allarity Therapeutics Outli...
$Allarity Therapeutics (ALLR.US)$Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
- Current Cash Balance of $20 million Expected to Provide Runway Into 2026
- Allarity to Pause Use of ATM
- Cap Table Successfully Cleaned Up
- Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment